Demographic Characteristics and Reasons for Progestin Subdermal Implant (PSI) Use: Inputs for Alternative Family Planning Method

Ma. Sandra Rivera; John Mark R. Asio

doi:10.55927/esa.v2i4.4840

Authors

Ma. Sandra Rivera College of Allied Health Studies, Gordon College, Olongapo City
John Mark R. Asio College of Allied Health Studies, Gordon College, Olongapo City

DOI:

https://doi.org/10.55927/esa.v2i4.4840

Keywords:

Family Planning, Progestin Subdermal Implant (PSI), Reproductive Health, Community Health Development

Abstract

This study aims to analyze the demographic characteristics and reasons for Progestin Subdermal Implant (PSI) use among selected women in Central Luzon, Philippines. The study used descriptive-correlation research on 75 volunteer women using purposive sampling. The study observed significant differences in age, occupation, educational attainment, number of living children, type of family planning used before PSI use, reasons for practicing family planning, type of birth delivery, and plan to have another baby. Lastly, significant relationships were found in the same demographic characteristics and reason for the PSI use. The study concluded that there exists variation in the use of PSI and association for the benefit of PSI among the respondents.

Downloads

Download data is not yet available.

References

Abasiattai, A.M., Utuk, N.M., & Inyang-Etoh, E.C. (2014). Subdermal contraceptive implants: Profile of acceptors in a tertiary hospital in Southern Nigeria. International Journal of Gynecology, Obstetrics and Neonatal Care, 1(1), 9-13. https://cosmosscholars.com/phms/index.php/ijgonc/article/view/72

Abdalla, K. K. (2020). Prevalence of and factors associated with modern contraceptive use among female sex workers in Dar Es Salaam, Tanzania. Muhimbili University of Health and Allied Sciences Institutional Repository. http://dspace.muhas.ac.tz:8080/xmlui/handle/123456789/2850

Bachorik A, Friedman J, Fox A, Nucci AT, Horowitz CR, & Diaz A. (2015). Adolescent and young adult women's knowledge of and attitudes toward etonogestrel implants. Journal of Pediatric and Adolescent Gynecology, 28, 229– 233. https://doi.org/10.1016/j.jpag.2014.08.002

Balogun, O.R., Olaomo, N., Adeniran, A.S., & Fawole, A.A. (2014). Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria. Journal of Medical and Biomedical Sciences, 3(1), 1-5. https://doi.org/10.4314/jmbs.v3i1.1

Britton, L. E., Alspaugh, A., Greene, M. Z., & McLemore, M. R. (2020). CECE: An Evidence-Based Update on Contraception. The American Journal of Nursing, 120(2), 22–33. https://doi.org/10.1097/01.NAJ.0000654304.29632.a7

Edwards, M., & Can, ASAS (2023). Progestin. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK563211/

Fiato, Natalie (2016) Family planning in Sub-Saharan Africa: a review of interventions in the promotion of long-acting reversible contraception. Master's Thesis, University of Pittsburgh. (Unpublished). http://d-scholarship.pitt.edu/id/eprint/27371

Inthavong, S., Pantasri, T., Morakote, N., Muangmool, T., Piyamongkol, W., Pongsatham S., & Chaovisitseree, S. (2022). Change of contraceptive preference after the free LARC program for Thai teenagers. BMC Women's Health, 22, 211. https://doi.org/10.1186/s12905-022-01797-9

Jacobstein, R. (2018). Liftoff: The blossoming of contraceptive implant use in Africa. Global Health: Science and Practice, 6(1), 17-39. https://doi.org/10.9745/GHSP-D-17-00396

Jacobstein, R., & Polis, C.B. (2014). Progestin-only contraception: Injectables and implants. Best Practice & Research Clinical Obstetrics & Gynaecology, 28(6), 795-806. https://doi.org/10.1016/j.bpobgyn.2014.05.003

Kolawole, O.O., Sowemimo, O.O., Ojo, OOOO, & Fasubaa, O.B. (2018) Contraceptive implants: A review and current perspective in southwest Nigeria. Tropical Journal of Obstetrics and Gynaecology, 35, 108-12. https://doi.org/10.4103/TJOG.TJOG_6_18

Krogstad, E.A., Odhiambo, O.K., Ayallo, M., Bailey, V.C., Rees, H., & van der Straten, A. (2019). Contraceptive implant uptake in Kenya versus South Africa: Lessons for new implantable technologies. Contraception, 101, 220-225. https://doi.org/10.1016/j.contraception.2020.01.001

Liu, S., Kciuk, O., Frank, M., & Tyson, N. (2022). Progestin today and tomorrow. Current Opinion in Obstetrics and Gynecology, 34(6), 344-350. https://doi.org/10.1097/GCO.0000000000000819

Madugu, N., Abdul, M., Bawa, U., & Kolawole, B. (2015). Uptake of hormonal implants contraceptive in Zaria, Northern Nigeria. Open Journal of Obstetrics and Gynecology, 5, 268-273. https://doi.org/10.4236/ojog.2015.55039.

Mayoche, Justin. (2022). A study of barriers and facilitators of access to family planning services by adolescent girls in selected secondary schools in Lukulu District. Cavendish Repository. http://155.0.3.194:8080/jspui/

Mitchell, V.E., & Welling, L.L.M. (2020). Not all Progestins are created equally: Considering unique Progestins individually in psychobehavioral research. Adaptive Human Behavior and Physiology, 6, 381–412. https://doi.org/10.1007/s40750-020-00137-1

Olaifa, B. T., Okonta, H. I., Mpinda, J. B., & Govender, I. (2022). Reasons were given by women for discontinuing the use of progestogen implants at Koster Hospital, North West province. South African Family Practice: Official Journal of the South African Academy of Family Practice/Primary Care, 64(1), e1–e7. https://doi.org/10.4102/safp.v64i1.5471

Quijencio, Jr., W.D. (2021). Variations in the Clinico-demographic profile among progestin subdermal implant acceptors. Globus International Journal of Medical Science, Engineering & Technology, 10(2), 11-16. https://doi.org/10.46360/globus.met.320212003

Rademacher, K. H., Vahdat, H. L., Dorflinger, L., Owen, D. H., & Steiner, M. J. (2013). Global introduction of a low-cost contraceptive implant. Critical Issues in Reproductive Health, 33, 285–306. https://doi.org/10.1007/978-94-007-6722-5_14

Riedel, E.M.C., Turner, D.T., Kobeissi, L.H., Karyotaki, E., Say, L., & Cuijpers, P. (2020). The impact of psychosocial interventions on condom and contraceptive use in LMICs: Meta-analysis of randomized controlled trials, Global Public Health, 15(8), 1182-1199. https://doi.org/10.1080/17441692.2020.1744679

Sah S., Jaiswal., A., & Paul, P. (2018). Current status of contraceptive use. World Journal of Pharmaceutical Research, 7(14), 320-331. https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1531725186.pdf

Santiago, M.S., Pastrana, M.L. (2022). Prevalence and determinants of long-acting reversible contraception initiation among teenage mothers in a tertiary hospital. Philippine Journal of Obstetrics and Gynecology, 46, 210-217. https://doi.org/10.4103/pjog.pjog_39_22

Van, V.T.S., Uy, J., Bagas, J., & Ulep, V.G.T. (2021). Trends in national-level governance and implementation of the Philippines’ Responsible Parenthood and Reproductive Health Law from 2014 to 2020. Global Health: Science and Practice, 9(3), 5348-564. https://doi.org/10.9745/GHSP-D-21-00184

Waris, N., & Fatima, R.M. (2022). Frequency of various side effects and early removal of progesterone implant among females attending family planning clinics. Pakistan Journal of Medical & Health Sciences, 16(1), 637-638. https://doi.org/10.53350/pjmhs22161637

Weisberg, E., Bateson, D., McGeechan, K., & Mohapatra, L. (2014) A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system. The European Journal of Contraception & Reproductive Health Care, 19(1), 5-14. https://doi.org/10.3109/13625187.2013.853034